Who benefits the most from etrolizumab in ulcerative colitis?
Crossref DOI link: https://doi.org/10.1038/nrgastro.2015.197
Published Online: 2015-11-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2015-11-18
Article History
First Online: 18 November 2015